Public Joint-Stock Company "Human Stem Cells Institute"

Public Joint-Stock Company "Human Stem Cells Institute" - Dividend Historyverified

ISKJ.ME

Price:

$42.74

Market Cap:

$3.49B

Public Joint-Stock Company "Human Stem Cells Institute," identified by the symbol ISKJ.ME, operates primarily as a biotechnology enterprise within Russia. The company focuses on pharmaceutical innovation, encompassing research, development, and the commercialization of its proprietary offerings in various therapeutic areas. These include regenerative medicine, bio-insurance, medical genetics (with a specific emphasis on reproductive applications), gene therapy, and biopharmaceutics. The institute manages Gemabank, a prominent family cord blood stem cell repository serving Russia and the Commonwealth of Independent States (CIS), and Reprobank, a facility for the personal cryopreservation of r...[Read more]

Industry

Biotechnology

IPO Date

2010-03-03

Stock Exchange

MCX

Ticker

ISKJ.ME

ISKJ.ME Dividend History Overview

Dividends are a key part of long-term returns for investors, and Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) has a track record worth reviewing. Looking at dividend history for ISKJ.ME gives you an idea of how consistent the dividends have been and what you might expect in the future.

Ex-Dividend Date

2026-06-22

Dividend Yield

2.81%

Annual Dividend

$1.20

P/E Ratio

164.38

Payout Ratio

0.35

Dividend per Share

$1.20

EPS

0.26

Ex-Date/EFF DateDividend AmountAdjusted DividendPayment DateDeclaration Date
2026-06-22$1.2$1.22026-07-06
2024-06-17$94.0032$94.0032
2023-07-18$78.336$78.336
2016-06-29$23.5008$23.50082016-08-012016-05-17
2014-06-27$11.7504$11.75042014-08-012014-05-19
2010-04-26$7.8336$7.83362010-07-01

Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) Dividend History Chart

The table below shows Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.

Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) Dividend Growth

Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.

Other Popular Dividend Stocks

Check out the dividend history of other popular stocks:

Stock nameDividend yield

Track & Identify Dividend Stocks

Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.

Custom stock screener in Wisesheets

You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) without the pain and hassle of copy pasting data.

Custom stock screener in Wisesheets

Frequently asked questions❓

What is dividend history?

How do I check past dividend history?

What does the ex-dividend date mean?

What is ISKJ.ME’s dividend yield?

What is the difference between regular and special dividends?

Has ISKJ.ME increased its dividends over time?

Why might dividend history data be delayed?

How often does ISKJ.ME pay dividends?

What factors impact ISKJ.ME's dividend payments?

Can dividends change over time?

What is ISKJ.ME’s next dividend date?